SMYD2 and acute myeloid leukemia: We note that, albeit not significantly deregulated during lymphomagenesis, Smyd3 is expressed in mouse B-cells [9]: whether combined loss of Smyd2 and Smyd3 may affect lymphomagenesis - or may further impair AML progression - remains to be addressed.